Document Detail


The alteration of coagulation in patients with thyroid dysfunction.
MedLine Citation:
PMID:  22074577     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The influence of thyroid dysfunction on haemostasis is complex and still not very well understood. Both bleeding tendency and hypercoagulable states have been reported. In this article, we attempt to discuss the possible relationship between thyroid dysfunction and secondary haemostasis and fibrinolysis. After the analysis of the recent literature, we conclude that thyroid dysfunction is associated with alterations in fibrin generation and fibrinolysis. Most of the evidence suggests that hyperthyroidism is associated with impaired fibrinolysis and enhanced coagulation. Although, former studies proposed that there was an increase in fibrinolytic activity in hypothyroidism, increasing number of recent reports advocated the opposite. We believe that further prospective comprehensive clinical studies involving large numbers of patients either with overt or subclinical thyroid dysfunctions should be performed to clarify the effect of thyroid dysfunction on secondary haemostasis and fibrinolysis. Recent important patents focusing on coagulation and thyroid dysfunction are also discussed in this review.
Authors:
Baris Akinci; Abdurrahman Comlekci; Mehmet A Ozcan
Related Documents :
15795697 - A comparative study of the role of erythropoietin in the pathogenesis of deficient eryt...
6822797 - Impact of spirometry on the management of chronic obstructive airway disease.
19075557 - Biological markers in induced sputum of patients with different phenotypes of chronic a...
8209057 - Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic...
20571227 - Erythrocyte deformability in macrocytosis determined by means of ektacytometry techniques.
16820367 - Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Recent patents on endocrine, metabolic & immune drug discovery     Volume:  5     ISSN:  1872-2148     ISO Abbreviation:  Recent Pat Endocr Metab Immune Drug Discov     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101299743     Medline TA:  Recent Pat Endocr Metab Immune Drug Discov     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  50-7     Citation Subset:  IM    
Affiliation:
Division of Endocrinology of Metabolism, Department of Internal Medicine, Dokuz Eylul University Medical School, Inciralti, Izmir, 35340. Turkey. baris.akinci@dev.edu.fr.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exploring the Role of "Brahmi" (Bocopa monnieri and Centella asiatica) in Brain Function and Therapy...
Next Document:  Pituitary microadenoma treated with antipsychotic drug aripiprazole.